Arthramid Vet (2.5% polyacrylamide hydrogel) – formulation, mode of action, published research, indications for use, dose rate, post-injection protocols

Equine vets Dr Leigh de Clifford and Dr Jason Lowe present this webinar on Arthramid Vet, a 2.5% polyacrylamide hydrogel that is registered in New Zealand for treatment of osteoarthritis in horses.
Video Length: 1:23:18

They outline the formulation of the product and give extensive details on its mode of action. The webinar also covers various published research papers over a number of years. Indications for use for Arthramid Vet are explored as well as dose rates and post injection protocols.

Arthramid Vet is registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596.

Post your questions and comments below

Leave a Reply

Your email address will not be published.

Keep updated!

Sign up below to be notified when we post a new resource which you may be interested in.